The disclosure describes a method for treating motor neuron diseases by administering nucleic acid molecules encoding modulators of the heat shock protein Hsp70, such as mutant Hspa8, with specific characteristics such as missense mutations or altered domains. The gene discussed is HSPA8; the disease is motor neuron disorder.